$KATX
KAT EXPLORATION, INC.

2023 Q1 Form 10-K Financial Statement

#000168316823000914 Filed on February 14, 2023

View on sec.gov

Income Statement

Concept 2023 Q1 2022 Q4 2022
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $710.00 $4.510K $44.14K
YoY Change 239.54%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $712.00 $4.510K $44.14K
YoY Change -36.71% 239.55%
Operating Profit -$712.00 -$44.14K
YoY Change -36.71% 239.55%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $0.00 $0.00 $0.00
YoY Change
Pretax Income -$710.00 -$4.510K -$44.14K
YoY Change 239.54%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$712.00 -$4.510K -$44.14K
YoY Change -36.71% 239.55%
Net Earnings / Revenue
Basic Earnings Per Share $0.00 $0.00
Diluted Earnings Per Share $0.00 $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 1.794B shares 1.794B shares
Diluted Shares Outstanding 1.759B shares 1.794B shares

Balance Sheet

Concept 2023 Q1 2022 Q4 2022
SHORT-TERM ASSETS
Cash & Short-Term Investments $0.00 $130.00 $130.00
YoY Change
Cash & Equivalents $0.00 $125.00
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $0.00 $130.00 $130.00
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 -$5.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $0.00 $130.00 $130.00
Total Long-Term Assets $0.00 -$5.00 $0.00
Total Assets $0.00 $125.00 $130.00
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses $3.000K $3.000K $3.000K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $3.000K $22.27K $22.27K
YoY Change 71.31%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $0.00 $0.00
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $3.000K $22.27K $22.27K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $3.000K $22.27K $22.27K
YoY Change 71.28% 71.31%
SHAREHOLDERS EQUITY
Retained Earnings -$2.681M -$2.681M
YoY Change 1.67%
Common Stock $1.794M $1.794M
YoY Change 1.99%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$3.000K -$22.14K -$22.14K
YoY Change
Total Liabilities & Shareholders Equity $0.00 $125.00 $130.00
YoY Change

Cashflow Statement

Concept 2023 Q1 2022 Q4 2022
OPERATING ACTIVITIES
Net Income -$712.00 -$4.510K -$44.14K
YoY Change -36.71% 239.55%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$19.98K $120.00 -$34.88K
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $0.00 $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $19.85K 0.000 $35.00K
YoY Change
NET CHANGE
Cash From Operating Activities -$19.98K 120.0 -$34.88K
Cash From Investing Activities $0.00 $0.00
Cash From Financing Activities $19.85K 0.000 $35.00K
Net Change In Cash -$125.00 120.0 $124.00
YoY Change
FREE CASH FLOW
Cash From Operating Activities -$19.98K $120.00 -$34.88K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022 dei Entity Central Index Key
EntityCentralIndexKey
0001474558
CY2022 dei Amendment Flag
AmendmentFlag
false
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--11-30
CY2021 KATX Common Stock Issued For Cash
CommonStockIssuedForCash
usd
CY2021 us-gaap Valuation Allowances And Reserves Period Increase Decrease
ValuationAllowancesAndReservesPeriodIncreaseDecrease
0 usd
CY2022 us-gaap Valuation Allowances And Reserves Period Increase Decrease
ValuationAllowancesAndReservesPeriodIncreaseDecrease
0 usd
CY2022 dei Document Type
DocumentType
10-K
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-11-30
CY2022 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
87-2737873
CY2022 dei Entity Address Address Line1
EntityAddressAddressLine1
2313 Hollyhill Lane
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
Denton
CY2022 dei Document Transition Report
DocumentTransitionReport
false
CY2022 dei Entity File Number
EntityFileNumber
001-08589
CY2022 dei Entity Registrant Name
EntityRegistrantName
KAT Exploration, Inc.
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2022 dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
76205
CY2022 dei City Area Code
CityAreaCode
626
CY2022 dei Local Phone Number
LocalPhoneNumber
429.2780
CY2022 dei Security12b Title
Security12bTitle
Common Stock, no par value
CY2022 dei Trading Symbol
TradingSymbol
KATX
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Entity Current Reporting Status
EntityCurrentReportingStatus
No
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
No
CY2022 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022 dei Entity Small Business
EntitySmallBusiness
true
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022 dei Entity Shell Company
EntityShellCompany
true
CY2022Q2 dei Entity Public Float
EntityPublicFloat
2623371 usd
CY2023Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
1794271048 shares
CY2022 dei Auditor Firm
AuditorFirmId
5968
CY2022 dei Auditor Name
AuditorName
OLAYINKA OYEBOLA & CO.
CY2022 dei Auditor Location
AuditorLocation
Lagos Nigeria
CY2022Q4 us-gaap Cash
Cash
125 usd
CY2021Q4 us-gaap Cash
Cash
0 usd
CY2022Q4 us-gaap Assets
Assets
125 usd
CY2021Q4 us-gaap Assets
Assets
0 usd
CY2022Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
19266 usd
CY2021Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
13000 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3000 usd
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
0 usd
CY2022Q4 us-gaap Liabilities
Liabilities
22266 usd
CY2021Q4 us-gaap Liabilities
Liabilities
13000 usd
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1794271048 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1794271048 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1794271048 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1794271048 shares
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
1794271 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
1759271 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
864100 usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
864100 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2680513 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2636371 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-22142 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-13000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
125 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
0 usd
CY2022 us-gaap Revenues
Revenues
0 usd
CY2021 us-gaap Revenues
Revenues
0 usd
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
44142 usd
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
13000 usd
CY2022 us-gaap Operating Expenses
OperatingExpenses
44142 usd
CY2021 us-gaap Operating Expenses
OperatingExpenses
13000 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-44142 usd
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-13000 usd
CY2022 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 usd
CY2021 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-44142 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-13000 usd
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1794271048 shares
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1794271048 shares
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1759271048 shares
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1759271048 shares
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
0 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-13000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-13000 usd
CY2022 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
30000 usd
CY2022 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
5000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-44142 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-22142 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-44142 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-13000 usd
CY2022 us-gaap Increase Decrease In Operating Capital
IncreaseDecreaseInOperatingCapital
-9266 usd
CY2021 us-gaap Increase Decrease In Operating Capital
IncreaseDecreaseInOperatingCapital
-13000 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-34876 usd
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
0 usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
CY2022 KATX Common Stock Issued For Cash
CommonStockIssuedForCash
-35000 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
35000 usd
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
125 usd
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
0 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
125 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84D_eus-gaap--UseOfEstimates_zAj8n4hwD20k" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline"><span id="xdx_86C_zCtKU8wzSNK6">Use of Estimates</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates include the estimated useful lives of property and equipment. Actual results could differ from those estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2022 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_84F_eus-gaap--ConcentrationRiskCreditRisk_zQTz13hI6Onc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline"><span id="xdx_861_zewpFMjlWD2f">Concentrations of Credit Risk</span></span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Financial instruments that potentially expose the Company to concentration of credit risk consist primarily of cash and accounts receivable. The Company’s cash is deposited with major financial institutions. At times, such deposits may be in excess of the Federal Deposit Insurance Corporation insurable amount.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2022Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
125 usd
CY2020Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-44142 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2680513 usd
CY2022 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
0 usd
CY2021 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
0 usd
CY2022 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
0 usd
CY2021 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
0 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
0 usd
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
0 usd
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
-0 usd
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
-0 usd
CY2022Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 usd
CY2021Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 usd

Files In Submission

Name View Source Status
0001683168-23-000914-index-headers.html Edgar Link pending
0001683168-23-000914-index.html Edgar Link pending
0001683168-23-000914.txt Edgar Link pending
0001683168-23-000914-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
image_001.jpg Edgar Link pending
image_002.jpg Edgar Link pending
katx-20221130.xsd Edgar Link pending
kat_10k-ex3101.htm Edgar Link pending
kat_10k-ex3102.htm Edgar Link pending
kat_10k-ex3201.htm Edgar Link pending
kat_10k-ex3202.htm Edgar Link pending
kat_i10k-113022.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
katx-20221130_def.xml Edgar Link unprocessable
katx-20221130_cal.xml Edgar Link unprocessable
katx-20221130_pre.xml Edgar Link unprocessable
katx-20221130_lab.xml Edgar Link unprocessable
kat_i10k-113022_htm.xml Edgar Link completed